PGY2 Specialized Residency: Pediatrics
The UCSF PGY2 specialized residency program in pediatrics is designed to prepare pediatric clinical pharmacy specialists for practice in acute and ambulatory pediatric settings.
The pediatric residency is a one-year ASHP-accredited specialty residency that allows the opportunity for the pediatric resident to strengthen his/her clinical skills by focusing on providing pharmaceutical care to pediatric patients. UCSF Benioff Children’s Hospital is a 189-bed children’s hospital and is part of UCSF Medical Center. The children’s hospital includes 58 neonatal ICU beds, 37 hematology/oncology/BMT beds, 28 general pediatric and surgical beds, 28 transitional care beds (transplant and cardiac step-down), 38 ICU beds, and 42 obstetrics and labor and delivery beds. The primary emphasis of the program is to provide in-depth clinical experience in a variety of areas within pediatric and neonatal medicine. The pharmacy resident will be a core member of the interdisciplinary medical team during the acute care rotations and will participate in patient care rounds on a daily basis. There is also a significant teaching component associated with this residency program and the resident will earn a teaching certificate. The UCSF Medical Center is closely affiliated with the UCSF School of Pharmacy, and the resident will have the opportunity to teach Doctor of Pharmacy students in two courses in the School of Pharmacy and precept Doctor of Pharmacy students throughout the year.
At a minimum, each resident will spend two thirds or more of their time involved in direct patient care activities. Residents must complete 5 core rotations which can be customized to accommodate for a longer experience and may be repeated to incorporate advanced learning experience elements. Multiple electives may be selected based on the amount of time available after initial customization of core rotations.
Sequencing of learning experiences
Initial rotation sequencing based on resident rotation preferences. Sequencing and scheduled learning experiences are modified and customized during the year based on resident interest and performance. Final elective rotation at the end of the year can be decided upon later in the year based on resident preference.
- General Pediatrics (5-6 weeks)
- Neonatal Intensive Care Nursery-ICN I (4 weeks)
- Pediatric Intensive Care Unit-PICU I (4 weeks)
- Cardiac Intensive Care Unit-CICU I (4 weeks)
- Hematology/Oncology I (5-6 weeks)
- Administration (48 weeks)
- Pediatric BMT Clinic-Fall/Spring (20-24 weeks)
- Pediatric Renal Transplant Clinic-Fall/Spring (20-24 weeks)
- Pharmacy Operations (48 weeks)
- Research/Projects/DUE (48 weeks)
- Education (48 weeks)
- Bone Marrow Transplant I (4-5 weeks)
- Infectious Disease I, II (4 weeks)
- Solid Organ Transplant (Kidney, Liver, Heart) (4 weeks)
- Emergency Medicine (5-6 weeks)
- Labor & Delivery - Obstetrics (2-4 weeks)
- Critical Care - PICU II, CICU II, ICN II
- Oncology/BMT - Heme/Onc II, BMT II
All residents receive comprehensive training in each of the operational areas during orientation, including formalized training in sterile compounding and aseptic technique. At the beginning of the residency year, residents are paired with an experienced preceptor who will oversee their operational staffing learning experience through the year and provide residents with summative feedback.
Operational staffing occurs longitudinally and takes place approximately every third weekend spanning throughout the residency year for a total of 15 weekends. Residents staff in the main pharmacy. Residents interested in additional chemotherapy satellite training may be trained and can staff in this area in addition to the main pharmacy.
The Residency Program Director collects project proposal submissions from clinical pharmacists for consideration as a resident research project on an annual basis in the Spring. Projects are reviewed for feasibility, appropriateness of timeline, potential value that may focus on clinical pharmacist services, quality improvement initiatives such as drug safety, optimal medication use, cost effective drug use, and efficient, safe and effective medication preparation, delivery and administration. The Residency Program Director will reach out to the residents in early summer to start discussion of project selection.
PGY2 residents participate in the UCSF Research Certificate Program and will gain skills in: adhering to a research timeline, creating an appropriate study design and methodology, completing data collection and analysis and summarizing research findings. Residents are enrolled in the Designing Clinical Research course. This interprofessional curriculum within the Department of Epidemiology & Biostatistics guides residents through modification of their research proposal and creation of a version suitable for submission to the UCSF Institutional Review Board. For projects requiring more advanced statistics, residents also receive support to work with the Clinical and Translational Science Institute (CTSI) in order to complete analysis. Residents will participate in a research certificate whereby they attend structured research sessions throughout the year in guiding the successful completion of the research project.
Poster & platform presentations
All projects are of a scope suitable for publication. Projects are presented as posters at the UCSF Department of Clinical Pharmacy Spring Research Poster Session. They are also presented as posters at the Vizient residency session that precedes the ASHP Midyear Clinical Meeting. The final presentation occurs in spring as a platform presentation at the PPAG National meeting and UC Collaborative Conference in California. Final research project write up should be in a format suitable journal submission.
Previous PGY2 Pediatrics Resident Research Projects
|Prophylactic Antibiotics in Endoscopic Retrograde Cholangiopancreatography in Pediatric Patients|
|Nancy Koo||Evaluation of a Delirium Risk Factor Screening Tool as a Predictor of Incidence of Delirium|
Retrospective comparison of calfactant versus poractant alfa in premature neonates
Evaluation of the impact of the Pediatric Critical Care Comfort Algorithm (CALM) sedation weaning protocol on medication use in the Pediatric Intensive Care Unit (PICU)
Utilization and Monitoring of Methadone in Pediatrics
Impact of using population pharmacokinetic model-based dosing algorithm for initial dosing of busulfan in children less than 12 kilograms
Utilization of QT prolonging medications in a tertiary children’s hospital
Retrospective investigation of busulfan pharmacokinetics and potential drug-interactions that impact drug exposure in pediatric patients undergoing hematopoietic stem cell transplantation
Development and Implementation of the Withdrawal Evaluation of Analgesia for Neonates (WEAN) Protocol
Characterization of Tacrolimus levels in Pediatric Kidney Transplant Patients
Use of Vancomycin Continuous Mediastinal Irrigation in Pediatric Patients
A Prolonged Gentamicin Dosing Interval Achieves Target Drug Concentrations in Neonates with Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
Evaluation of New Valganciclovir Dosing Recommendations for Cytomegalovirus (CMV) in Pediatric Patients – A Monte Carlo Analysis
Teaching is a focus of the residency at UCSF, and residents receive a Teaching Certificate upon program completion if they complete the required elements of the program. The certificate recognizes the significant contributions and skills that are attained during the residency year. Residents receive training in teaching methodology, precepting and small group conference facilitation through a variety of educational seminars that are planned during the year.
Teaching opportunities may include the following:
- Precepting of PGY1, APPE, and IPPE students on clinical rotations and project-based work
- Large group teaching
- Pediatric Elective Lecture
- Continuing Pharmacy Education (Department of Pharmaceutical Services)
- Small group teaching
- Interprofessional education to nursing & physician groups
- Conference Leader for Pediatric Elective & Therapeutics courses
- Roundtable teaching sessions
PGY2 Pediatric Pharmacy residents are integral members of the interprofessional emergency response care team. All PGY2 Pediatric Residents will become certified in Pediatric Advanced Life Support (PALS), and receive hands-on pediatric & adult code training. Residents respond to Code White (Pediatric), Code Blue (Adult), Seizure Rescue and participate in adult and pediatric stroke response. During emergent response, residents ensure appropriate drug selection and administration, timeliness of medication retrieval and preparation, adjusting medication dosages and monitoring for response.
PGY2 Pediatric Residents will participate in multidisciplinary mock codes throughout the year in both pediatric and adult clinical practice areas to practice their skills.
Salary & benefits
$58,700 per year, paid monthly
Medical/Dental/Vision Plan and Professional Liability Insurance
Vacation / professional / sick leave
All residents will receive 10 days of paid vacation, and 10 days of paid professional leave. Professional leave may be used to attend professional meetings, and for post-graduate or professional job interviews. Additionally, all residents will receive up to 12 days of paid sick leave per academic year.
All residents are provided with a stipend to support travel, lodging, and registration fees for the purposes of professional conferences. The amount of the travel stipend is determined each year and may not cover all travel expenses.
Residents will be provided with a UCSF white coat, scrubs, personal pager, iPad and access to the resident office workspace. Meal cards are provided with a value determined by the number of staffing hours assigned.
July 6, 2020 to July 5, 2021
PGY2 Pediatric (NMS 635061) – 2 positions
The Residency Program Director and residents recruit potential residency applicants at the following events:
- American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting
- Residency Showcase
- Personnel Placement Services (PPS)
- Applicants are encouraged to participate in PPS if possible
Requirements for admission
Applicants must be a graduate of an ACPE-accredited college of pharmacy or otherwise be eligible for licensure in California. Additionally, applicants must be participating in, or have completed, an ASHP-accredited PGY1 pharmacy residency program or one in the ASHP accreditation process (i.e., one with candidate or preliminary accreditation status).
Non-US and US citizens from foreign schools of pharmacy
Non-US citizens must be eligible to work and live in the US by obtaining an appropriate visa and must be eligible to work as a licensed pharmacist in California. We do not sponsor visas for foreign pharmacy residency applicants. Non-US and US citizens who graduate from a foreign school of pharmacy must first be certified by examination before the process of licensure in the US can begin. The Foreign Pharmacy Graduate Equivalency Committee ™ (FPGEC®) certificate program operates under the auspices of the National Association of Boards of Pharmacy®. The NABP® provides the FPGEC Certification Program as a means of documenting the educational equivalency of a candidate's foreign education, as well as the license and or registration to practice pharmacy. More information about this entire process is provided in these NABP® links: nabp.pharmacy.
How to apply
- Match: All applicants must register for The Match – ASHP Resident Matching Program.
- PhORCAS: Applications will be accepted through PhORCAS (Pharmacy Online Residency Centralized Application Service), a web-based pharmacy residency application system. The application deadline is December 31st.
- Cover Letter: A cover letter describing the elements of the program that most interest you and how each element relates to your personal goals is also required.
- Letters of Recommendation: We request a minimum of one (two is preferred) of your three references should come from a preceptor who you have worked with in a clinical setting, related to an APPE in acute or ambulatory care. The clinical preceptor should be able to comment on your scope of responsibility, total patient load, level of autonomy, clinical abilities, and organizational and time management skills. All 3-reference writers should use the standard PhORCAS template to submit their candidate recommendation and comment on a minimum of 7 of the 13 listed candidate characteristics.
- Supplemental Application Materials: A response to the following essay statement is required for acceptance. The essay response should be no longer than one page in length. An application will not be reviewed if this statement is missing. Please note that the essay is separate from your cover letter. (NOTE: The essay response should be uploaded in the Supplemental Information section in PhORCAS. Space is limited to a max of 5 MB and must be provided in the following format: .pdf, .doc, .txt, .rtf.)
Each PGY2 applicant packet is screened and scored by members of the Pediatrics team. Screeners assess the following: communication skills, clinical experience (breadth, performance, scope of activity), personal/environmental factors (maturity, confidence, motivation, and adaptability), and work experience, aggregate letters of recommendation, leadership/initiative, teaching (interest and/or experience), research (interest and/or experience), extracurricular involvement and academic performance. The screening score is used to determine if an on-site interview will be extended.
The interview process is a full day which consists of a pediatric pharmacist panel interview as well as personal interviews with the Residency Program Director, pharmacy administrator, operational supervisor, medical faculty, and will receive a campus tour. Applicants are also asked to present a 20-min Powerpoint presentation as well as participate in a clinical question session. Lunch is provided and will be with current Pediatric PGY2 residents.
PGY2 Pediatric interviews will be held on the following dates for the upcoming interview cycle:
- Monday, January 27th, 2020
- Friday, January 31st, 2020
- Monday, February 3rd, 2020
- Friday, February 7th, 2020
- Monday, February 10th, 2020
Sarah Scarpace Lucas, PharmD, BCPS, BPPS
Residency Program Director, PGY2 Pediatrics
Senior Pharmacist Supervisor – Clinical Services
Pediatric Clinical Pharmacist, UCSF Medical Center/UCSF Benioff Children’s Hospital
Clinical Professor, UCSF School of Pharmacy
Education & Post-Graduate Training
BS Pharmacy, University of Wisconsin-Madison (1999)
Doctor of Pharmacy, University of Wisconsin-Madison (2000)
Pediatric Specialty Residency – St. Louis Children’s Hospital (2001)
1975 Fourth Street, Room C4411G
San Francisco CA 94158
Rebecca Deoras, PharmD, BPPS
Residency Program Coordinator, PGY2 Pediatrics
Pediatric Clinical Pharmacist, UCSF Medical Center/UCSF Benioff Children’s Hospital
Assistant Clinical Professor, UCSF School of Pharmacy
Education & Post-Graduate Training
Doctor of Pharmacy, University of Pittsburgh (2007)
PGY1 Pharmacy Practice, Children’s National Health System (2011)
PGY2 Pediatric Pharmacy, Children’s National Health System (2012)
1975 Fourth Street, Room C4411
San Francisco CA 94158